GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Piotroski F-Score

SDZNY (Sandoz Group AG) Piotroski F-Score : 4 (As of Mar. 24, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sandoz Group AG has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Sandoz Group AG's Piotroski F-Score or its related term are showing as below:

SDZNY' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 4   Max: 4
Current: 4

During the past 3 years, the highest Piotroski F-Score of Sandoz Group AG was 4. The lowest was 4. And the median was 4.


Sandoz Group AG Piotroski F-Score Historical Data

The historical data trend for Sandoz Group AG's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Piotroski F-Score Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24
Piotroski F-Score
N/A N/A 4.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24
Piotroski F-Score N/A - N/A - 4.00

Competitive Comparison of Sandoz Group AG's Piotroski F-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sandoz Group AG's Piotroski F-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Net Income was $0 Mil.
Cash Flow from Operations was $656 Mil.
Revenue was $10,384 Mil.
Gross Profit was $4,926 Mil.
Average Total Assets from the begining of this year (Dec23)
to the end of this year (Dec24) was (19430 + 19907) / 2 = $19668.5 Mil.
Total Assets at the begining of this year (Dec23) was $19,430 Mil.
Long-Term Debt & Capital Lease Obligation was $4,666 Mil.
Total Current Assets was $7,801 Mil.
Total Current Liabilities was $6,307 Mil.
Net Income was $77 Mil.

Revenue was $9,979 Mil.
Gross Profit was $4,564 Mil.
Average Total Assets from the begining of last year (Dec22)
to the end of last year (Dec23) was (17557 + 19430) / 2 = $18493.5 Mil.
Total Assets at the begining of last year (Dec22) was $17,557 Mil.
Long-Term Debt & Capital Lease Obligation was $4,230 Mil.
Total Current Assets was $7,572 Mil.
Total Current Liabilities was $5,698 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sandoz Group AG's current Net Income (TTM) was 0. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Sandoz Group AG's current Cash Flow from Operations (TTM) was 656. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec23)
=0/19430
=0

ROA (Last Year)=Net Income/Total Assets (Dec22)
=77/17557
=0.00438572

Sandoz Group AG's return on assets of this year was 0. Sandoz Group AG's return on assets of last year was 0.00438572. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Sandoz Group AG's current Net Income (TTM) was 0. Sandoz Group AG's current Cash Flow from Operations (TTM) was 656. ==> 656 > 0 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec23 to Dec24
=4666/19668.5
=0.23723212

Gearing (Last Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=4230/18493.5
=0.22872901

Sandoz Group AG's gearing of this year was 0.23723212. Sandoz Group AG's gearing of last year was 0.22872901. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec24)=Total Current Assets/Total Current Liabilities
=7801/6307
=1.23687966

Current Ratio (Last Year: Dec23)=Total Current Assets/Total Current Liabilities
=7572/5698
=1.32888733

Sandoz Group AG's current ratio of this year was 1.23687966. Sandoz Group AG's current ratio of last year was 1.32888733. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Sandoz Group AG's number of shares in issue this year was 434. Sandoz Group AG's number of shares in issue last year was 431.2. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=4926/10384
=0.47438367

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4564/9979
=0.45736046

Sandoz Group AG's gross margin of this year was 0.47438367. Sandoz Group AG's gross margin of last year was 0.45736046. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec23)
=10384/19430
=0.53443129

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec22)
=9979/17557
=0.56837729

Sandoz Group AG's asset turnover of this year was 0.53443129. Sandoz Group AG's asset turnover of last year was 0.56837729. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+1+0+1+0+0+0+1+0
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Sandoz Group AG has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Sandoz Group AG  (OTCPK:SDZNY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Sandoz Group AG Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sandoz Group AG Business Description

Address
Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as the first US biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in its pipeline.